Oric PharmaceuticalsÂ Inc (ORIC) Financials

$12.86

$0.12 (0.94%)

As on 04-Sep-2026 16:00EDT

Market cap

$1,333 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.58	1.22	1.11	1.03	0.97	0.90
Gross Profit	-0.58	-1.22	-1.11	-1.03	-0.97	-0.90
Operating Expenses	155.55	141.78	141.79	109.75	91.77	78.87
Operating Profit (EBIT)	-156.14	-143.00	-142.90	-110.78	-91.77	-78.87
Other Income	--	--	--	--	--	0.02
Profit before Tax	-140.35	-129.47	-127.85	-100.70	-89.12	-78.72
Provision for Tax	--	--	--	--	2.36	-1.04
Profit after Tax (Net Income)	-140.35	-129.47	-127.85	-100.70	-89.12	-77.68
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-89.12	-78.72

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	381.26	384.36	243.12	224.09	222.35	272.98
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.67	6.22	6.17	10.14	12.62	10.52
Current Liabilities	20.76	20.42	24.85	20.46	15.39	15.15
Total Liabilities	425.44	411.00	274.14	254.69	250.36	298.64

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	130.99	122.54	11.89	42.09	39.90	58.12
Current Assets	273.70	288.47	262.25	212.60	210.46	240.52
Total Assets	425.44	411.00	274.14	254.69	250.36	298.64
Total Debt*	3.33	11.55	3.18	10.21	12.10	1.93
Net Current Assets	252.94	268.05	237.40	192.14	195.07	225.37

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-113.37	-112.66	-85.69	-75.14	-59.54
Cash Flow from Investing Activities	--	-148.03	22.14	-43.40	-109.25	158.44
Cash from Financing Activities	--	247.66	126.55	85.66	25.23	49.13
Net Cash Inflow / Outflow	--	--	--	--	-159.17	148.03

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.40	-1.47	-1.81	-1.75	-2.22	-1.97
Cash EPS ($)	-1.31	-1.46	-1.79	-1.73	-2.20	-1.95
Adjusted Book Value ($)	3.68	4.38	3.44	3.90	5.54	6.93
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.29	-1.59	-1.49	-1.87	-1.51
Free Cash Flow per Share ($)	--	-1.30	-1.61	-1.51	-1.92	-1.54

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-40.32	-53.20	-42.96	-34.99	-27.51
ROE (%)	-36.66	-41.27	-54.73	-45.11	-35.99	-27.61
ROA (%)	-35.52	-37.79	-48.35	-39.88	-32.47	-25.99
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	-517,846.67
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-5.03	-1.27	-26.96	-16.05	-10.01	-59.84
Net Profit Growth (%)	-2.26	-1.27	-26.96	-12.99	-14.73	-5.39
EPS Growth (%)	26.00	0.19	-0.03	0.21	-0.13	0.10
Book Value Growth (%)	-14.89	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-5.55	-4.46	-5.25	-2.65	-7.45
Price / Book Value	3.51	1.87	2.35	2.36	1.06	2.12
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.13	-3.49	-2.50	-3.32	-0.49	-4.41
Close Price ($)	10.83	8.18	8.07	9.20	5.89	14.70
High Price ($)	14.93	14.93	16.63	9.79	16.76	39.45
Low Price ($)	7.23	3.90	6.33	4.09	2.36	11.28
Market Cap ($ Cr)	1,332.97	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.03	0.01	0.05	0.05	0.01
Short term debt to equity ratio	0.01	0.01	0.01	0.01	0.01	0.01
Current Ratio	13.19	14.13	10.56	10.39	13.68	15.87
Quick Ratio	13.19	--	--	--	--	--
Interest Coverage	--	--	--	--	-32.80	-559.37

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	804.15	411.11	400.64	606.10	538.10
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.